The most expensive study is one you have to repeat. 10 things to know before you start your GLP study.

Good laboratory practice (GLP) studies are an essential component to medical product development and regulatory submissions. They are highly rigorous, are conducted in compliance with a  legally bound code of federal regulations (21 CFR Part 58) and should be conducted by qualified scientists and staff of an accredited contract research organization (CRO). They are also…

How GCMI helps Georgia Tech faculty members convert research into innovative medical products – Our one-on-one interview with Dr. Omer Inan

GCMI’s foremost goal as an affiliate of the Georgia Institute of Technology is to partner with Georgia Tech faculty and engineers in the innovation process of new medical products. One successful example of this partnership has been our work with Dr. Scott Hollister. With GCMI’s help, Children’s Healthcare of Atlanta surgeons used Dr. Hollister’s process…

GCMI and Rambam Medical Center Accelerator Evaluating 12 Israeli Startups for U.S. Commercialization.

In October 2018, GCMI and Rambam Medical Center announced the formation of a partnership to help Israeli medtech innovators commercialize their products in the U.S. healthcare market. Earlier this year, Georgia Bio and the Atlanta Chamber of Commerce recognized our work with a 2019 Phoenix Award recognizing leaders who have forged academic and industry relationships…

Children’s Healthcare of Atlanta, Georgia Tech, and GCMI collaborate in Georgia’s first procedure to place a 3D-printed tracheal splint in a pediatric patient

Last August a multi-disciplinary team contributed to Georgia’s first surgery to place 3D-printed tracheal splints in a pediatric patient. The patient who received the groundbreaking surgery is a 7-month-old boy battling both congenital heart disease and tracheo-bronchomalacia, a condition that causes severe life-threatening airway obstruction. During his six-month inpatient stay in the Pediatric Intensive Care…

GCMI and BOTLab included in The New York Times: “Looking to Technology to Avoid Doctor’s Offices and Emergency Rooms.”

Revolutionizing the provision of patient care, improving outcomes and reducing overall cost through new medical technologies is serious business. It takes vision, technical prowess and efficient use of scarce resources in a rigorous regulatory landscape. Last month, The New York Times included the work GCMI and the American Cancer Society are doing with Dr. Darren…

Ares Health Systems’ learnings and next steps after 12 months in GCMI’s accelerator program

Last year, Ares Health Systems became the first digital health company to enter GCMI’s accelerator, accessing our digital health commercial development expertise and health system relationships to further validate the value of Ares’ MPower care management platform and commence market penetration. “Our confidence in our value proposition has increased since we’ve last talked,” says Ares…